Detailed Narrative
Strong Financial Performance in Q3 and 9M FY26
Park Medi World Limited delivered robust financial results for Q3 and nine months ended December 31, 2025. Revenue from operations for Q3 FY26 stood at INR4,100 million, marking an 18% year-on-year growth. For the nine-month period, revenue reached INR12,189 million, a 17% increase from the previous year. EBITDA for Q3 FY26 was INR994 million with a 24% margin, while nine-month EBITDA was INR3,170 million at a 26% margin. Profit after tax for the nine-month period grew significantly by 40% year-on-year to INR1,968 million, demonstrating strong operating leverage and cost management.
Operational Efficiency and Patient Metrics Improvement
The company showcased improved operational metrics, with average occupancy across its network rising to 65% for the nine months FY26, up from 62% in the prior year, despite the addition of 250 beds. Average Revenue Per Occupied Bed (ARPOB) increased to INR27,406 from INR25,500, reflecting an enhanced product mix. The Average Length of Stay (ALOS) remained stable at 6.34 days, indicating efficient clinical processes. Footfall also saw a 24% growth, reaching 6.6 lakhs patients in 9M FY26 compared to 5.32 lakhs in 9M FY25.
Strategic Expansion and Capacity Growth
Park Medi World is executing a cluster-based expansion strategy, focusing on building dense regional clusters. The company currently operates 14 multi-specialty hospitals with 3,250 beds. It plans to add 660 beds in FY26 (Agra 360, Panchkula 300), 500 beds in FY27 (Kanpur 300, Delhi 200), and 850 beds in FY28 (Gorakhpur 400, Ambala Ext 200, Rohtak 250), bringing the total to 5,260 beds by FY28. This expansion, including the acquisition of KPS Institute of Medical Sciences in Agra for INR245 crores, is projected to maintain an EBITDA of 27%, PAT of 17%, ROCE of 21%, and ROE of 23% by FY28.
Imminent Debt-Free Status
The company is on the verge of becoming completely debt-free. From a pre-IPO debt of INR425 crores, INR380 crores have already been repaid. As of January 31, 2026, the remaining term debt stands at INR15 crores, which the company plans to repay in February 2026. This significant debt reduction enhances the company's financial stability and provides greater flexibility for future growth initiatives.
Advanced Technology Adoption and Clinical Leadership
Park Medi World continues to invest in advanced medical technology, including robotic-assisted surgeries. The company has acquired three Da Vinci fifth-generation robots and performs complex procedures like robotic heart surgery, joint replacements, organ transplants, and neuro-interventions. This investment has improved the product mix, led to faster patient recovery, reduced hospital stays, and increased ARPOB. The company's doctor-led professional management model, with a low consultant attrition rate of 18.9%, ensures high clinical quality and patient-centric decision-making.
Payer Mix Evolution and Receivable Management
The company's payer mix currently stands at 83% government and 17% private, with a target to shift to 75% government and 25% private in a year's time. While 93% of government payments are from the central government, ensuring high quality, the collection cycle is longer. Management aims to reduce the receivable days from the current 4.5 months to 4 months by FY26 end, and further to 3.5 months going forward⏳, through internal process improvements and government initiatives.